Science Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Date:
July 21, 2014
Source:
TheStreet / Powered by NewsLook.com
Summary:
New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet


Related Videos

last updated on 2015-02-01 at 11:51 am EST

Single Dose HIV Drug Launched

Single Dose HIV Drug Launched

AFP (Apr. 8, 2013) — South Africa's health minister launches a new single dose anti-AIDS drug, which reduces the need for HIV positive patients to take multiple pills each day. The country has the largest HIV positive population in the world.
Powered by NewsLook.com
India's Alarming Child Male-Female Ratio Worries Experts

India's Alarming Child Male-Female Ratio Worries Experts

NDTV (May 7, 2013) — It is not a girl's world, at least not in India where there are only 919 girls under six for every 1000 boys. The 2011 census figures show the ratio has fallen further from the already alarming 927 girls for every 1000 boys ten years ago.
Powered by NewsLook.com
Mississippi Baby Has HIV Again, Cure Hopes Take A Hit

Mississippi Baby Has HIV Again, Cure Hopes Take A Hit

Newsy (July 10, 2014) — The anonymous infant's "functional cure" last year raised hopes of a treatment for HIV-positive babies, but the virus finally re-emerged in the girl. Video provided by Newsy
Powered by NewsLook.com
Finding a Cure Faster: Gay Rights, PhRMA, and a Plague

Finding a Cure Faster: Gay Rights, PhRMA, and a Plague

FORA.tv (May 9, 2013) — Dr Joep Lange has been involved in HIV research and treatment since 1983. He has been the architect and principal investigator of several pivotal trials on antiretroviral therapy and on the prevention of mother-to-child transmission of HIV in both the developed and developing world. In addition to various positions at the AMC, he was Chief of Clinical Research and Drug Development at the Global program on AIDS of the World Health Organization in Geneva from 1992 to 1995. From 2002-2004 he was President of the International AIDS Society.
Powered by NewsLook.com

Related Stories


Share This



Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins